Alka Chaubey is double board-certified in clinical cytogenetics/genomics and clinical molecular genetics/genomics by the American Board of Medical Genetics and Genomics (ABMGG). Dr. Chaubey has developed several innovative products including a low-pass whole genome sequencing, FSHD1 assay, CytoScan Xon microarray and Vanadis NIPT technology to the market. Previously, Dr. Chaubey has held positions at PerkinElmer Genomics and the Greenwood Genetic Center, SC, USA. She also holds an academic appointment as the Scientific Director of the Georgia Esoteric and Molecular Laboratory, and Adjunct Assistant professor of Pathology of the Medical College of Georgia at Augusta University.